Cargando…

Surviving pediatric intensive care: physical outcome after 3 months

OBJECTIVE: This study investigated the prevalence and nature of physical and neurocognitive sequelae in pediatric intensive care unit (PICU) survivors. DESIGN AND SETTING: Prospective follow-up study 3 months after discharge from a 14-bed tertiary PICU in The Netherlands. PATIENTS AND PARTICIPANTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Knoester, Hendrika, Bronner, Madelon B., Bos, Albert P.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480486/
https://www.ncbi.nlm.nih.gov/pubmed/18357437
http://dx.doi.org/10.1007/s00134-008-1061-4
Descripción
Sumario:OBJECTIVE: This study investigated the prevalence and nature of physical and neurocognitive sequelae in pediatric intensive care unit (PICU) survivors. DESIGN AND SETTING: Prospective follow-up study 3 months after discharge from a 14-bed tertiary PICU in The Netherlands. PATIENTS AND PARTICIPANTS: The families of 250 previously healthy children unexpectedly admitted to the PICU were invited to visit the outpatient follow-up clinic for structured medical examination of the child 3 months after discharge; 186 patients were evaluated. MEASUREMENTS AND RESULTS: Pediatric Cerebral Performance Category (PCPC) and Pediatric Overall Performance Category (POPC) values were determined at PICU discharge, at the outpatient follow-up clinic, and retrospectively before admission to the PICU. We found that 69% of children had physical sequelae. In 30% of cases these were caused by a previously unknown illness and in 39% by acquired morbidity. In 8% of the children the acquired morbidity was related to complications from PICU procedures. Three months after discharge 77% of the children had normal PCPC scores and 31% had normal POPC scores. CONCLUSIONS: Our results indicate that PICU survival may be associated with substantial physical sequelae. Structured follow-up research, preferably by multicenter studies, is warranted in PICU survivors.